Q32 Bio Inc. Share Price
QTTBQ32 Bio Inc. Stock Performance
Open $5.44 | Prev. Close $5.53 | Circuit Range N/A |
Day Range $5.28 - $5.66 | Year Range $1.34 - $8.01 | Volume 14,373 |
Average Traded $5.51 |
Q32 Bio Inc. Share Price Chart
About Q32 Bio Inc.
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human antiinterleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.
Q32 Bio Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
30-Apr-26 | $5.44 | $5.66 | +0.00% |
30-Apr-26 | $5.44 | $5.66 | -1.48% |
28-Apr-26 | $5.51 | $5.75 | +4.74% |
27-Apr-26 | $5.20 | $5.49 | -12.66% |
24-Apr-26 | $6.61 | $6.28 | -3.38% |
23-Apr-26 | $6.41 | $6.50 | -1.59% |
22-Apr-26 | $6.61 | $6.61 | +3.77% |